Vietnam Plans To Strengthen Oversight Of Pharma Sector
This article was originally published in PharmAsia News
Vietnamese authorities plan steps they say will stimulate growth in the pharmaceutical industry, centering on production in the antibiotics field. The separate ministries of health and trade and industry jointly plan changes in the manufacturing, marketing, investment and distribution of pharmaceuticals. A detailed plan expected soon is to add to the country's 171 pharma factories with plants devoted to making antibiotics and antibiotic materials and complying with good manufacturing practices. The government plans to strengthen Vietnam's drug inspection, add drug products to its national trade program and establish a retail system for pharmaceuticals. (Click here for more
You may also be interested in...
With some studies about to finish and others on clinical hold, the coronavirus vaccine field approaches an infection point as the US FDA prepares for its first advisory committee on the topic. Our charts and graphics offer a quick look at what stands where.
Funds will be used to expand European sales of the CE-marked Lenire device, scale-up manufacturing and progress US regulatory and reimbursement plans.
RB CEO Laxman Narasimhan sees the potential for the company to establish a global supplements business built on the successes it has enjoyed in the US and China. The comments came as RB reported solid growth in the third quarter, despite struggles for its OTC brands.